Petrulienė, K.; Žiginskienė, E.; Kuzminskis, V.; Nedzelskienė, I.; Bumblytė, I.A.
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Medicina 2017, 53, 90-100.
https://doi.org/10.1016/j.medici.2017.03.001
AMA Style
Petrulienė K, Žiginskienė E, Kuzminskis V, Nedzelskienė I, Bumblytė IA.
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Medicina. 2017; 53(2):90-100.
https://doi.org/10.1016/j.medici.2017.03.001
Chicago/Turabian Style
Petrulienė, Kristina, Edita Žiginskienė, Vytautas Kuzminskis, Irena Nedzelskienė, and Inga Arūnė Bumblytė.
2017. "Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients" Medicina 53, no. 2: 90-100.
https://doi.org/10.1016/j.medici.2017.03.001
APA Style
Petrulienė, K., Žiginskienė, E., Kuzminskis, V., Nedzelskienė, I., & Bumblytė, I. A.
(2017). Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Medicina, 53(2), 90-100.
https://doi.org/10.1016/j.medici.2017.03.001